REXULTI® (brexpiprazole) agitation that may happen with dementia due to Alzheimer's disease
Por um escritor misterioso
Last updated 12 março 2025

Discover the only FDA-Approved treatment for agitation that may happen with dementia due to Alzheimer’s disease. See Important Safety Info and Full Prescribing Info, including Boxed WARNING.

First Treatment for Alzheimer's Agitation Approved by FDA

REXULTI® (brexpiprazole) Patient Information Website

FDA Approves First Drug to Treat Dementia-Associated Agitation in AD Patients

Rexulti Commercial #2 (2023)
REXULTI® (brexpiprazole), SZ

FDA Approves First Drug to Treat Agitation Symptoms Associated with Dementia due to Alzheimer's Disease

Insights & Implications in Gerontology: Agitation in Alzheimer's Disease by GSAStrategicAlliances - Issuu
Japan's Otsuka Pharma-Lundbeck Partnered Depression Drug Gets FDA Approval For Alzheimer's Agitation
Rexulti: Uses, Side Effects & Warnings